Skip to content

A retrospective cohort study evaluating the treatment outcome and prognosis after endoscopic resection using ligation device (EMRL) for colorectal neuroendocrine tumors (NET)

A retrospective cohort study evaluating the treatment outcome and prognosis after endoscopic resection using ligation device (EMRL) for colorectal neuroendocrine tumors (NET) - Efficacy of EMRL and prognosis of rectal NETs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000032648
Enrollment
180
Registered
2018-05-19
Start date
2018-05-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal neuroendocrine tumors (NET)

Interventions

None listed

Sponsors

NTT Medical Center Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with colorectal NET

Exclusion criteria

Exclusion criteria: 1. Cases in which it is difficult to get informed consent 2. Cases which are considered as inappropriate by doctors

Design outcomes

Primary

MeasureTime frame
Completion rare/R0 resection rate Recurrence rate

Secondary

MeasureTime frame
Procedure time, complication rate (perforation, delayed-bleeding), pathological findings

Countries

Japan

Contacts

Public ContactEiji Sakai

NTT Medical Center Tokyo Department of Gastroenterology

eiji525@yokohama-cu.ac.jp03-3448-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026